Major Events - Four Seasons Pharmaceutical (00460) invests in Swiss Suisselle to accelerate global medical aesthetics business expansion [1] - Basilea Pharmaceutica-B (02616) to announce Phase I dose-escalation clinical data for PD-1/VEGF/CTLA-4 triple antibody and latest research design for ROR1 ADC [1] - Hengrui Medicine (01276) subsidiary receives drug clinical trial approval notice [1] - Huajian Medical (01931) acquires U.S. property and establishes U.S. subsidiary ETHK BANK to promote stablecoins and intellectual property securitization in the U.S. [1] - China National Pharmaceutical Group (01177): TQB2102 "HER2 dual antibody ADC" included in breakthrough therapy designation program [1] Operating Performance - 361 Degrees (01361): Retail sales of 361° main brand products in Q3 increased by approximately 10% year-on-year [1] - Xinhua Insurance (01336) expects net profit attributable to shareholders for the first three quarters to increase by 45% to 65% year-on-year [1] - Country Garden (02007) achieved contract sales amounting to approximately 2.58 billion yuan in September [1] - Dekang Agriculture and Animal Husbandry (02419) sold approximately 7.55 million pigs and generated sales revenue of approximately 14.28 billion yuan in the first nine months [1] - Longfor Group (00960) achieved total contract sales amount of 50.75 billion yuan in the first nine months [1]

Core Viewpoint - 361 Degrees (01361.HK) is expected to achieve significant retail growth across its main brand, children's clothing, and e-commerce platforms by the third quarter of 2025 compared to the same period in 2024 [1] Retail Performance - The retail revenue of 361° main brand products is projected to see approximately 10% positive growth in Q3 2025 compared to Q3 2024 [1] - The retail revenue of 361° children's clothing products is also expected to grow by around 10% in Q3 2025 compared to Q3 2024 [1] - The overall sales volume of 361° e-commerce platform products is anticipated to increase by about 20% in Q3 2025 compared to Q3 2024 [1] Brand Strategy and Innovation - In Q3 2025, 361° aims to enhance its brand influence and market competitiveness through product technological innovation, sponsorship of professional events, and diversified collaboration activities [1] - The company has strategically partnered with Stand Robot (Wuxi) Co., Ltd. to integrate smart technology into its brand, marking a new phase in brand intelligence advancement [1]